[Antirheumatic agents for treatment of rheumatoid arthritis].
Yamanaka
Hisashi
H
D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003545:Cysteine / Q000031:analogs & derivatives; D006052:Gold Sodium Thiomalate; D006801:Humans; D007555:Isoxazoles; D000077339:Leflunomide; D008727:Methotrexate; D010597:Pharmacogenetics; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D012460:Sulfasalazine; D013997:Time Factors
D018501:Antirheumatic Agents; D007555:Isoxazoles; D006052:Gold Sodium Thiomalate; D012460:Sulfasalazine; D000077339:Leflunomide; D003545:Cysteine; C026535:bucillamine; D008727:Methotrexate